Analysis of intracellular doxorubicin and its metabolites by ultra-high-performance liquid chromatography

Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer

E O’Brien, Nely Wigler, Moshe Inbar et al. · Annals of Oncology · 2004 · 1.7K citations · Full text

Liposomal Doxorubicin Hcl, Metastatic Breast Cancer, Oncology +8

Development of the polymer micelle carrier system for doxorubicin

Takeshi Nakanishi, Shigeto Fukushima, Kazuya Okamoto et al. · Journal of Controlled Release · 2001 · 565 citations

Polymer Chemistry, Micelle, Drug Delivery System +1

UPLC^™: An Introduction and Review

Michael E. Swartz · Journal of Liquid Chromatography & Related Technologies · 2005 · 560 citations

Engineering, Particle Chemistry Performance, Separation Science +14

Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinol.

Richard D. Olson, Phillip S. Mushlin, Dean E. Brenner et al. · Proceedings of the National Academy of Sciences · 1988 · 352 citations · Full text

Doxorubicin Cardiotoxicity, Heart Failure, Pathology +16

Selective Delivery of Adiramycin to a Solid Tumor Using a Polymeric Micelle Carrier System

M. Yokoyama, Teruo Okano, Yu Sakurai et al. · Journal of drug targeting · 1999 · 211 citations

Engineering, Solid Tumor, Biomedical Engineering +16